Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Basic Clin Pharmacol Toxicol ; 134(6): 770-777, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38566316

RESUMEN

Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterised by the progressive loss of specific neuronal cell populations due to multifactorial factors, including neurochemical and immunological disturbances. Consequently, patients can develop cognitive, motor and behavioural dysfunctions, which lead to impairments in their quality of life. Over the years, studies have reported on the neuroprotective properties inherent in phenolic compounds. Therefore, this review highlights the most recent scientific findings regarding phenolic compounds as promising neuroprotective molecules against neurodegenerative diseases.


Asunto(s)
Fármacos Neuroprotectores , Fenoles , Fármacos Neuroprotectores/farmacología , Animales , Humanos , Fenoles/farmacología , Enfermedades Neurodegenerativas/tratamiento farmacológico , Enfermedad de Alzheimer/tratamiento farmacológico , Modelos Animales de Enfermedad , Enfermedad de Parkinson/tratamiento farmacológico , Neuroprotección/efectos de los fármacos
2.
Int J Biol Macromol ; 112: 1248-1256, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29427681

RESUMEN

This study assessed the antioxidant, antimicrobial, anticancer and neuroprotective activities of the kappa(k)-carrageenan isolated from the red alga Hypnea musciformis (Hm-SP). The chemical spectrum of the k-carrageenan from Hm-SP was confirmed by Fourier transform infrared (FT-IR) spectroscopy. Hm-SP revealed an antibacterial and antifungal action against Staphylococcus aureus and Candida albicans, respectively. Hm-SP did not promoted cytotoxic effects against Human breast cancer (MCF-7) and Human neuroblastoma (SH-SY5Y) cell-lines. However, it was observed a significant reduction of the cellular proliferation capacity in these cancer cells in presence of the Hm-SP. Furthermore, Hm-SP showed neuroprotective activity in 6-hydroxydopamine-induced neurotoxicity on SH-SY5Y cells by modulation of the mitochondria transmembrane potential and reducing Caspase 3 activity. In addition, Hm-SP demonstrates low antioxidant potential and did not induce significant cytotoxic effects or changes in the cell proliferation on Balb/c 3T3 mouse fibroblast cell-line. In summary, our data suggest that Hm-SP shows antimicrobial, anticancer and neuprotective activities.


Asunto(s)
Antibacterianos/farmacología , Antineoplásicos/farmacología , Carragenina/aislamiento & purificación , Carragenina/farmacología , Fármacos Neuroprotectores/farmacología , Rhodophyta/química , Animales , Antioxidantes/farmacología , Muerte Celular/efectos de los fármacos , Línea Celular , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Humanos , Ratones , Pruebas de Sensibilidad Microbiana , Neurotoxinas/toxicidad , Oxidopamina , Espectroscopía Infrarroja por Transformada de Fourier
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...